Record Information |
---|
Version | 2.0 |
---|
Created at | 2024-08-12 09:46:52 UTC |
---|
Updated at | 2024-09-16 10:47:02 UTC |
---|
NP-MRD ID | NP0333729 |
---|
Natural Product DOI | https://doi.org/10.57994/3208 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 6-O-ethylzephyranine E |
---|
Description | It was first documented in 2024 (PMID: 39313750). Based on a literature review a significant number of articles have been published on 6-O-ethylzephyranine E (PMID: 39313741) (PMID: 39313725) (PMID: 39313684) (PMID: 39313682). |
---|
Structure | [H][C@]12C[C@H](CC[C@@]11CCN2[C@@H](OCC)C2=CC(OC)=C(OC)C=C12)OC InChI=1S/C20H29NO4/c1-5-25-19-14-11-16(23-3)17(24-4)12-15(14)20-7-6-13(22-2)10-18(20)21(19)9-8-20/h11-13,18-19H,5-10H2,1-4H3/t13-,18-,19-,20-/m0/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C20H29NO4 |
---|
Average Mass | 347.4550 Da |
---|
Monoisotopic Mass | 347.20966 Da |
---|
IUPAC Name | (1S,8S,10S,12S)-8-ethoxy-4,5,12-trimethoxy-9-azatetracyclo[7.5.2.0^{1,10}.0^{2,7}]hexadeca-2,4,6-triene |
---|
Traditional Name | (1S,8S,10S,12S)-8-ethoxy-4,5,12-trimethoxy-9-azatetracyclo[7.5.2.0^{1,10}.0^{2,7}]hexadeca-2,4,6-triene |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@]12C[C@H](CC[C@@]11CCN2[C@@H](OCC)C2=CC(OC)=C(OC)C=C12)OC |
---|
InChI Identifier | InChI=1S/C20H29NO4/c1-5-25-19-14-11-16(23-3)17(24-4)12-15(14)20-7-6-13(22-2)10-18(20)21(19)9-8-20/h11-13,18-19H,5-10H2,1-4H3/t13-,18-,19-,20-/m0/s1 |
---|
InChI Key | LRRYCKWQNAHRIL-KJYZGMDISA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
HMBC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | NOESY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | H2BC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
citrina | | |
|
---|
Chemical Taxonomy |
---|
Classification | Not classified |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Chen Z, Li X, Xu G, Xiao T, Wang D, Wang C, Zhang K, Li J, Pan Y, Qiao Y, Zhang Y: Synergize Strong and Reactive Metal-Support Interactions to Construct Sub-2 nm Metal Phosphide Cluster for Enhanced Selective Hydrogenation Activities. Angew Chem Int Ed Engl. 2024 Sep 23:e202413788. doi: 10.1002/anie.202413788. [PubMed:39313750 ]
- Hirai T, Aoyama T, Tsuji Y, Ino K, Ikejiri M, Tawara I, Iwamoto T: Pharmacokinetic Model of Drug Interaction of Tacrolimus with Combined Administration of CYP3A4 Inhibitors Voriconazole and Clarithromycin After Bone Marrow Transplantation. Eur J Drug Metab Pharmacokinet. 2024 Sep 24. doi: 10.1007/s13318-024-00915-2. [PubMed:39313741 ]
- Beghini A, Aimo A, Ambrosy AP, Tomasoni D: Modulating energy metabolism to treat non-obstructive hypertrophic cardiomyopathy? Insights from IMPROVE-HCM. Heart Fail Rev. 2024 Sep 23. doi: 10.1007/s10741-024-10440-8. [PubMed:39313725 ]
- Frank S, Lessa Derci Augustynczik A, Havlik P, Boere E, Ermolieva T, Fricko O, Di Fulvio F, Gusti M, Krisztin T, Lauri P, Palazzo A, Wogerer M: Enhanced agricultural carbon sinks provide benefits for farmers and the climate. Nat Food. 2024 Sep;5(9):742-753. doi: 10.1038/s43016-024-01039-1. Epub 2024 Sep 23. [PubMed:39313684 ]
- Mills ES, Wang JC, Richardson MK, Chung BC, Mayer LW, Gallo MC, Alluri RK, Hah RJ, Heckmann ND: The change in lumbar lordosis from the standing to the lateral position: implications for lateral interbody fusion. Eur Spine J. 2024 Sep 23. doi: 10.1007/s00586-024-08493-2. [PubMed:39313682 ]
|
---|